Activation of AR sensitizes breast carcinomas to NVP-BEZ235's therapeutic effect mediated by PTEN and KLLN upregulation.

Molecular Cancer Therapeutics
Yu WangCharis Eng

Abstract

NVP-BEZ235 is a newly developed dual PI3K/mTOR inhibitor, being tested in multiple clinical trials, including breast cancer. NVP-BEZ235 selectively induces cell growth inhibition in a subset, but not all, breast cancer cell lines. However, it remains a challenge to distinguish between sensitive and resistant tumors, particularly in the pretreatment setting. Here, we used ten breast cancer cell lines to compare NVP-BEZ235 sensitivity and in the context of androgen receptor (AR) activation during NVP-BEZ235 treatment. We also used female SCID mice bearing breast tumor xenografts to investigate the beneficial effect of dihydrotestosterone/NVP-BEZ235 combination treatment compared with each alone. We found that AR-positive breast cancer cell lines are much more sensitive to NVP-BEZ235 compared with AR-negative cells, regardless of PTEN or PI3KCA status. Reintroducing AR expression in NVP-BEZ235 nonresponsive AR-negative cells restored the response. DHT/NVP-BEZ235 combination not only resulted in a more significant growth inhibition than either drug alone, but also achieved tumor regression and complete responses for AR(+)/ER(+) tumors. This beneficial effect was mediated by dihydrotestosterone (DHT)-induced PTEN and KLLN expression...Continue Reading

References

May 1, 1995·The Journal of Steroid Biochemistry and Molecular Biology·S N BirrellW D Tilley
Aug 6, 2002·Molecular and Cellular Endocrinology·S AndòM Lanzino
Aug 26, 2003·Human Mutation·Charis Eng
Nov 26, 2004·Journal of the American Society of Nephrology : JASN·Yunxia TaoCharles L Edelstein
May 27, 2006·Endocrine-related Cancer·Marc LacroixGuy Leclercq
Feb 23, 2007·Molecular Cancer Research : MCR·Antoinette HollestelleMieke Schutte
Apr 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yong-Jig Cho, Peng Liang
Oct 24, 2008·International Journal of Clinical Oncology·Yoshinari OgawaYukio Nishiguchi
Mar 27, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Iram ZafarCharles L Edelstein
Dec 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Saskia M BrachmannSauveur-Michel Maira
Dec 24, 2010·JAMA : the Journal of the American Medical Association·Kristi L BennettCharis Eng
Jun 3, 2011·The Journal of Clinical Investigation·Brian D LehmannJennifer A Pietenpol
Aug 31, 2011·Proceedings of the National Academy of Sciences of the United States of America·Nina IlicThomas M Roberts
Sep 3, 2011·PLoS Neglected Tropical Diseases·Rosario Diaz-GonzalezMichael P Pollastri
Sep 29, 2011·Nature Chemical Biology·Markus K MuellnerSebastian M B Nijman
Dec 7, 2011·The Biochemical Journal·Greg C SmithPeter R Shepherd
May 23, 2012·International Journal of Oncology·Rachel M SquillaceVictor M Rivera

❮ Previous
Next ❯

Citations

Feb 26, 2016·British Journal of Haematology·Ma Carmen Herrero-SánchezBelén Blanco
Aug 21, 2016·BMC Cancer·I A NetlandD Goplen
Dec 21, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M BrandãoE de Azambuja
Oct 2, 2019·Cold Spring Harbor Perspectives in Medicine·Joanne Ngeow, Charis Eng
Oct 22, 2016·Journal of Hematology & Oncology·Mª Carmen Herrero-SánchezBelén Blanco
Feb 21, 2019·Molecular Cancer·Jing YangXiawei Wei
Jan 8, 2019·The Journal of Clinical Investigation·Lamis YehiaCharis Eng
Oct 12, 2019·Experimental and Therapeutic Medicine·Ronglin ChenJiefu Lu
Aug 18, 2020·Science China. Life Sciences·Song-Yang WuYi-Zhou Jiang
Jan 25, 2018·Hormones & Cancer·Bianca Facchim GonçalvesWellerson Rodrigo Scarano
Aug 14, 2019·Seminars in Cancer Biology·VarRuchi SharmaPanneerselvam Priya

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.